S. George Barreto (@sgeorgebarreto) 's Twitter Profile
S. George Barreto

@sgeorgebarreto

GI, HPB & Liver Transplant Surgeon👨🏻‍⚕️ Researcher🔬 Teacher 📚 Dy. Director (Flinders MD) 🇦🇺 #heforshe Member @WorldJSurg 💪🏽 Soccer Enthusiast ⚽️🕎

ID: 1489582843411898372

linkhttps://www.flinders.edu.au/people/savio.barreto calendar_today04-02-2022 12:53:42

1,1K Tweet

838 Followers

319 Following

AJG - The American Journal of Gastroenterology (@amjgastro) 's Twitter Profile Photo

📢New ACG Guideline: Gastric Premalignant Conditions Highlights: 🚨GPMC Dx 🚨endoscopic & nonendoscopic management 🚨histology criteria & reporting 🚨H. pylori eradication 🚨autoimmune gastritis 🚨gastric epithelial polyps Read: bit.ly/acg-gpmc-2025

📢New ACG Guideline: Gastric Premalignant Conditions

Highlights:
🚨GPMC Dx
🚨endoscopic & nonendoscopic management 
🚨histology criteria & reporting
🚨H. pylori eradication
🚨autoimmune gastritis 
🚨gastric epithelial polyps

Read: bit.ly/acg-gpmc-2025
Annals of Surgery (@annalsofsurgery) 's Twitter Profile Photo

Complexity and experience grading to guide patient selection for minimally-invasive pancreatoduodenectomy: An ISGPS Consensus. journals.lww.com/annalsofsurger…

Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Disappoints me that we keep publishing these types of articles. I worry people who don’t understand stats, selection, or biology will take this as a green light to operate. M1 dz is a contraindication to operate for PDAC. Full stop. ⁦SURGERY Journal⁩ surgjournal.com/article/S0039-…

Layal Al Mahmasani (@layalmahmasani) 's Twitter Profile Photo

Honored to co-author this review with the exceptional Eileen M O’Reilly, a true leader, mentor, and inspiration. Thank you for your guidance on "Precision Oncology in Pancreatic Cancer and Future Treatment Directions" - full text here: surgonc.theclinics.com/article/S1055-…

Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

We’re often told that cancer outcomes are improving. And in many ways, that’s true. But recent data suggest a more nuanced story, especially for younger adults. A new study in Cancer Discovery (Shiels et al., 2025) examined U.S. trends in cancer incidence (2010–2019) and

We’re often told that cancer outcomes are improving. And in many ways, that’s true.

But recent data suggest a more nuanced story, especially for younger adults.

A new study in Cancer Discovery (Shiels et al., 2025) examined U.S. trends in cancer incidence (2010–2019) and
Erman Akkus (@erman_akkus) 's Twitter Profile Photo

EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma - Journal of Hepatology journal-of-hepatology.eu/article/S0168-…

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Wow! Preclinical study with some empirical human correlates but this Cell paper suggests a potential anti tumor role for SSRIs through invigoration of T cell responses by serotonin transport inhibition. cell.com/cell/fulltext/…

Wow! Preclinical study with some empirical human correlates but this <a href="/CellCellPress/">Cell</a> paper suggests a potential anti tumor role for SSRIs through invigoration of T cell responses by serotonin transport inhibition. 
cell.com/cell/fulltext/…
Adam Grant (@adammgrant) 's Twitter Profile Photo

The most underrated career skill is the ability to receive tough love. Acquiring knowledge is easy. Obtaining constructive criticism is hard. If you can't handle the truth, people stop telling you the truth. The people who grow the most are the ones who take feedback the best.

BJS Open (@bjsopen) 's Twitter Profile Photo

Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness ➡️doi.org/10.1093/bjsope… Patients with biologically borderline resectable pancreatic cancer—an

Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness
➡️doi.org/10.1093/bjsope…

Patients with biologically borderline resectable pancreatic cancer—an
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Understanding the Experiences of Patients With #PancreaticCancer: Quantitative Analysis of the PanCAN Patient Registry jopm.jmir.org/2025/1/e65046 Almost 90% of patients report pain, 2/3rd report depression. Reiterating the importance of multidisciplinary management beyond oncology.

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

A Nature Medicine paper from Geneseeq (China), which has developed a fragmentomics based MCED assay (CANSCAN): Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics nature.com/articles/s4159… Figure below on prospective asymptomatic cohort:

A <a href="/NatureMedicine/">Nature Medicine</a> paper from Geneseeq (China), which has developed a fragmentomics based MCED assay (CANSCAN): 
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics
nature.com/articles/s4159…
Figure below on prospective asymptomatic cohort:
Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study ⁦British Journal of Cancer⁩ nature.com/articles/s4141…

Zhi Ven Fong, MD MPH DrPH (@zhivenfongmd) 's Twitter Profile Photo

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to ASCO 2025 & trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown: MATTERHORN, & CASSANDRA! (Also tagging ppl who are smarter than me)

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to <a href="/ASCO/">ASCO</a> 2025 &amp; trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown:

MATTERHORN, &amp; CASSANDRA!

(Also tagging ppl who are smarter than me)
Adam Grant (@adammgrant) 's Twitter Profile Photo

A mark of wisdom is being quick to change your opinions but slow to change your principles. It takes openness to update your views. It takes integrity to uphold your values. A key to growth is raising your understanding without lowering your standards.

Erman Akkus (@erman_akkus) 's Twitter Profile Photo

Cancer treatment and survivorship statistics, 2025 - Wagle - CA: A Cancer Journal for Clinicians - Wiley Online Library acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…